Select your Market

Why Invest

We develop products and solutions that make life better – and have been successfully doing so for over 300 years. And when you’ve prospered for centuries as we have, you must have done a few things right.

It’s a great idea to invest in us – and here’s why

 

Related News

View All News
  1. Press Releases

    MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics' Gene ...

    MilliporeSigma signs five-year agreement to provide end-to-end testing services for Genetix Biotherapeutics' FDA-approved gene therapy portfolio.

    2026/05/07

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Opens €20 million Metrology and Inspection ...

    New site expands capacity for M&I tools fivefold, supporting chip manufacturers in advanced packaging and heterogeneous integration for AI chips.

    2026/05/05

  3. Information

    Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with ...

    Phase 3 program investigates enpatoran's potential to address underlying drivers of inflammation in lupus patients with skin manifestations

    2026/04/30

investors-shareprice2 investors-shareprice2
Share Price
Check Share Price
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.